Min Chen

Min Chen is a Scientist III and Principal Scientific Researcher at Genentech since December 2020. Prior experience includes serving as a Postdoctoral Fellow at Stanford University from September 2015 to December 2020, where significant contributions included the development of granzyme B-targeted probes for monitoring immunotherapy outcomes and supporting an Investigational New Drug (IND) filing for a PET probe targeting the caspase-3 enzyme. Min Chen earned a Doctor of Philosophy (PhD) in Chemical Biology from Fudan University in 2015 and participated as a Visiting Student in the Molecular Imaging Program at Stanford University in 2015.